课题基金 / 基金详情

Role of Miz1 in the Atr/Chk1 signalling pathway and in Myc-induced apoptosis

Role of Miz1 in the Atr/Chk1 signalling pathway and in Myc-induced apoptosis
Miz1 在 Atr/Chk1 信号通路和 Myc 诱导的细胞凋亡中的作用
批准号:
5422428
负责人:
Professor Dr. Martin Eilers
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Units
财政年份:
2004
资助国家:
德国
项目状态:
已结题
起止时间:
2003-12-31 至 2010-12-31

项目摘要

项目成果

Professor Dr. Martin Eilers的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The proto-oncogene c-myc plays a key role in the genesis of a wide variety of human tumours. Understanding how c-myc acts in tumorigenesis requires an understanding of its biochemistry and the protein/protein interactions through which Myc affects cell physiology. c-myc encodes a transcription factor (Myc) that can both activate and repress transcription. A heterodimeric complex of Myc with a partner protein, Max, mediates transcriptional activation by Myc. Repression by Myc is mediated by distinct protein complexes; the best characterized is a trimeric protein complex, which contains Myc, Max, and the zinc finger protein Miz1. We do not understand mechanistically how Myc can both activate and repress transcription. We have recently obtained evidence that two known co-factors of Myc, the hexameric ATPases Tip48 and Tip49, repress transcription through Myc and Miz1. We propose to follow the mechanistic clues provided by these findings. Second, our recent work on transcriptional activation by Myc has defined specific pathways of activation and has provided evidence for a functional role of mediator and p-TEFB complexes in Myc-mediat ed gene activation. We therefore propose to identify the underlying biochemical interactions and test their role in activation and repression.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting MYC-driven hepatocellular carcinoma via Aurora-A ligands
ShRNA Screening and Histopathology
  • 批准号:
    280454646
  • 项目类别:
    Research Units
  • 资助金额:
    $0.0万
  • 财政年份:
    2015
  • 负责人:
    Professor Dr. Martin Eilers
  • 依托单位:
Targeting MYC in pancreatic cancer
Systematic shRNA screens for the analysis of critical signaling pathways in KRAS-mutant multiple myeloma
国内基金
海外基金
Miz1在NASH相关肝癌中促进AhR/NF-κB通路失活和CD8+TRM驻留影响抗PD-1疗效的研究
  • 批准号:
    82371850
  • 项目类别:
    面上项目
  • 资助金额:
    46万元
  • 批准年份:
    2023
  • 负责人:
    张文杰
  • 依托单位:
Miz1在非酒精性脂肪性肝炎中调控肝细胞线粒体自噬及巨噬细胞炎症Cross-talk的机制研究
  • 批准号:
    82171737
  • 项目类别:
    面上项目
  • 资助金额:
    57万元
  • 批准年份:
    2021
  • 负责人:
    张文杰
  • 依托单位:
Miz1介导NF-kB通路激活调控巨噬细胞相关爆发性肝炎的机制研究
  • 批准号:
    82101850
  • 项目类别:
    青年科学基金项目(C类)
  • 资助金额:
    30.0万元
  • 批准年份:
    2021
  • 负责人:
    刘洋
  • 依托单位:
Miz1介导的线粒体自噬对肝癌免疫治疗反应性影响的机制研究
  • 批准号:
    81930086
  • 项目类别:
    重点项目
  • 资助金额:
    297.0万元
  • 批准年份:
    2019
  • 负责人:
    孙倍成
  • 依托单位: